Cervical Cancer Stage IIIC1
Reviewed by Oncology team, VICI Healthcare | Last updated: 2026-04
What Stage IIIC1 Means
Pelvic lymph node metastases (no distant metastases)
Treatment Approach for Stage IIIC1
Concurrent chemoradiation with pelvic node coverage (EBRT 45–50 Gy) + cisplatin weekly + brachytherapy
Survival Rates and Prognosis
The 5-year survival rate for cervical cancer at Stage IIIC1 is approximately 35–45%. Survival rates are statistical averages drawn from large patient populations and may not reflect your individual outcome. Factors that influence your specific prognosis include your age, overall health, tumour biology, and how well the cancer responds to treatment.
Important: These numbers are drawn from historical data. Newer treatments available today may improve outcomes beyond what published statistics show. Discuss your individual prognosis with your oncologist.
How Other Stages Compare
| Stage | 5-Year Survival | Treatment |
|---|---|---|
| Stage IA1 | 95–98% | Conization (cold knife, laser, or loop electrosurgical excision [LEEP]) with… |
| Stage IA2 | 93–95% | Radical trachelectomy (fertility-sparing) or radical hysterectomy with pelvic… |
| Stage IB1 | 80–90% | Radical hysterectomy with bilateral pelvic lymphadenectomy or concurrent… |
| Stage IB2 | 70–80% | Concurrent chemoradiation (cisplatin 40 mg/m2 weekly × 5–6 weeks +… |
| Stage IB3 | 60–75% | Concurrent chemoradiation (cisplatin weekly) + EBRT 45–50 Gy +… |
| Stage IIA1 | 75–85% | Radical hysterectomy with bilateral pelvic lymphadenectomy (if surgically fit)… |
| Stage IIA2 | 65–75% | Concurrent chemoradiation preferred (cisplatin weekly × 5–6 weeks +… |
| Stage IIB | 55–65% | Concurrent chemoradiation (cisplatin 40 mg/m2 weekly × 5–6 weeks +… |
| Stage IIIA | 40–50% | Concurrent chemoradiation (cisplatin weekly × 5–6 weeks + EBRT… |
| Stage IIIB | 30–40% | Concurrent chemoradiation (cisplatin 40 mg/m2 weekly × 5–6 weeks +… |
| Stage IIIC2 | 25–35% | Extended field radiation (EBRT 45–55 Gy to pelvis + para-aortic nodes) +… |
| Stage IVA | 15–20% | Pelvic exenteration (anterior and/or posterior) if good PS and no distant mets;… |
| Stage IVB | 5–15% | Palliative systemic chemotherapy (cisplatin + paclitaxel or carboplatin +… |
Cervical Cancer Treatment in Top Cities
Cervical Cancer in Gurgaon
Cervical Cancer in Noida
Cervical Cancer in Mumbai
Cervical Cancer in Bangalore
Cervical Cancer in Hyderabad
Cervical Cancer in Chennai
Cervical Cancer in Kolkata
Diagnosed with Stage IIIC1 Cervical Cancer?
Our specialists can review your reports and create a personalised treatment plan.